Zacks Investment Research on MSN
Amgen (AMGN) laps the stock market: Here's why
In the latest trading session, Amgen (AMGN) closed at $349.69, marking a +1.43% move from the previous day. This move outpaced the S&P 500's daily gain of 0.5%. On the other hand, the Dow registered a ...
Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...
If you want to know who really controls Amgen Inc. (NASDAQ:AMGN), then you'll have to look at the makeup of its share ...
Amgen Inc (AMGN) reached a significant milestone as its stock hit a 52-week high of $346.41. This marks a notable point for the biotechnology company, reflecting a positive trend over the past year.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...
Amgen's (NASDAQ:AMGN) 11% CAGR outpaced the company's earnings growth over the same five-year period
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...
Amgen says its MariTide obesity drug helped patients maintain weight loss for a second year, with good safety and fewer side ...
Amgen (NASDAQ: AMGN) has outperformed the market over the past 15 years by 1.17% on an annualized basis producing an average annual return of 13.01%. Currently, Amgen has a market capitalization of ...
Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results